We have reported previously that the cytolytic activity of murine CD8 ⍣ cytotoxic T lymphocytes (CTL) specific for HIV-1 gp160 envelope glycoprotein was markedly inhibited by brief exposure to the free minimal antigenic peptide (I-10: 10mer peptide from gp160) by direct binding to class I MHC molecules of specific CTL in the absence of antigen-presenting cells (APC). Here, we show that treatment of such CTL with the peptide induced not only the inhibition of cytolytic activity but also IL-2Rβ down-modulation, followed by the inhibition of IL-2-dependent growth. The peptidemediated inhibition and restoration of expression of IL-2Rβ were well correlated with changes in both cytolytic activity and IL-2-dependent growth of the CTL. Since enzymatic activity of granzyme B, and mRNA expression of granzyme B and perforin were significantly reduced in peptide-treated CTL, the inhibition of cytolytic activity was mainly caused by the exhaustion of cytolytic molecules. Moreover, treatment of the CTL with the epitopic peptide resulted in production of high levels of IL-2, IFN-γ, tumor necrosis factor-α and MIP-1β in the culture supernatant. Maximum amounts of cytokines were obtained in the culture supernatant when the level of cytolytic activity was the lowest. Thus, although the CTL temporarily lost their cytolytic activities, they simultaneously gained the abilities to produce cytokines for activation of various cell populations. These changes induced by free antigenic peptide in CD8 ⍣ CTL reveal an interesting counter-regulation between their cytolytic activities and cytokine production.
Introduction

TCR-mediated induction of IL-2 and IL-2 receptor (IL-2R)
2 responsiveness in anergic states have been well characterized in antigen-specific CD4 ϩ T cells. expression are the most important events in T cell activation required for G 1 progression and entry into S phase. However, In contrast, little is known about anergic states of antigenspecific CD8 ϩ T cells. Stimulation of CD8 ϩ cytotoxic T lymphoin the absence of co-stimulatory signals, engagement of the TCR on T cells with antigenic peptide presented by MHC cytes (CTL) incapable of producing IL-2 with immobilized anti-TCR mAb did not induce their proliferation (4-6) in molecules prevents the subsequent production of IL-2 and results in anergy for autocrine proliferation (1, 2) . These anergic response to subsequent antigen stimulation, whereas their specific cytolytic activities were retained. Otten et al. reported T cells are unable to produce IL-2, but they do proliferate in response to exogenous IL-2. On the other hand, when a that CD8 ϩ T cells capable of producing IL-2 were brought into anergy by exposure to antigen in the presence of fixed subset of T cells that cannot produce but require IL-2 for their growth is re-stimulated through the TCR after primary antigen-presenting cells (APC) (7). These anergic CD8 ϩ T cells failed to produce IL-2, but retained their cytolytic stimulation with antigen, IL-2 unresponsiveness and cell growth arrest are induced (3) . Thus, IL-2 production and ILactivities. Thus, in the case of anergic CD8 ϩ T cells, their cytolytic activities as well as their responses to antigens or HIV-1-IIIB gp160 gene-transfected BALB/c3T3 cells (1ϫ10 5 cells, named 15-12) in vitro (17) in 24-well plates containing IL-2 must be taken into consideration.
CD8 ϩ CTL recognize peptide epitopes in association with 1.5 ml of complete T cell culture medium which was composed of RPMI 1640 medium supplemented with 2 mM L-glutamine, MHC class I molecules on the target cells, and subsequently proliferate and kill the target cells. Several recent papers 1 mM sodium pyruvate, 0.1 mM non-essential amino acids, mixture of vitamins, 1 mM HEPES, 100 U/µl of penicillin, have described the inhibitory effects of free antigenic peptide on the CTL in the absence of other presenting cells. Various 100 µg/ml of streptomycin, 50 µM 2-mercaptoethanol, heatinactivated 10% FCS and 10% rat T-STIM (Collaborative effects have been reported, e.g. self-lysis of the CTL (8,9), loss of ability to lyse the target cells without self-lysis (10,11) Biomedical Products, Bedford, MA). The CTL lines were established and maintained by bi-weekly stimulation with and CTL-CTL killing (12,13). However, the effects of peptide differed between studies and thus the mechanisms respons-MMC-treated 15-12 cells and named LINE-IIIB cells. ible for inhibition of CTL is still controversial.
CTL assay We demonstrated previously that the cytolytic activity of murine CTL specific for HIV-1 gp160 envelope glycoprotein Cytotoxicity was assessed in a standard 4-6 h 51 Cr-release assay as described previously (17), with 51 Cr-labeled 15-12 was markedly inhibited by brief exposure to minimal free antigenic peptide and this was not due to fratricide or suicide cells as targets at various E:T ratios in 96-well U-bottomed culture plates. After incubation, the plates were centrifuged (apoptosis) (11). Since the inhibition of cytolytic activity by free antigenic peptide might affect the progress of viral and 100 µl of cell-free supernatants were collected to measure the radioactivity using a γ-counter. The percentage of specific diseases such as AIDS and chronic hepatitis, or of cancer, we performed the present study with a view to clarifying the 51 Cr release was calculated as: 100ϫ(experimental releasespontaneous release)/(maximum release -spontaneous mechanism responsible for the induction of CTL inhibition and to find a strategy for preventing CTL dysfunction or for release). Maximum release was determined from supernatants of cells lysed by addition of 5% Triton X-100. Spontaneous their recovery from their inactive state.
In this study, we demonstrated that brief treatment of the release was determined from target cells incubated without added effector cells. SEM of triplicate cultures was always CTL with free epitopic peptide induced not only the inhibition of cytolytic activity but also IL-2 unresponsiveness associated Ͻ3% of the mean. with the down-modulation of IL-2Rβ on the CTL. These findings Measurement of cell proliferation suggested the possibility of a close relationship between signaling through IL-2Rβ and the expression of cytolytic Peptide I-10 represents the minimal active epitope in the V3 loop of HIV-1 IIIB gp160 restricted by the D d class I MHC molecules. Moreover, we observed that such treatment of the CTL resulted in the high-level production of various cytokines molecule (14,18). The CTL were treated or untreated with 1 µM of peptide I-10 for 1 h, followed by washing to remove in the culture supernatants. Therefore, exposure of CTL to free epitopic peptide inhibits cytolytic activity but facilitates free peptide. The I-10-treated cells were seeded at a density of 1 or 5ϫ10 4 cells/well in 96-well flat-bottomed microtiter cytokine production. Based on these observations, we discuss here the unique feature of counter-regulation observed in plates and cultured in the presence or absence of 50 U/ml of human rIL-2 for 1, 2 or 3 days. Proliferation was measured CD8 ϩ CTL generated by free antigenic peptide.
by addition of 0.5 µCi [ 3 H]thymidine/well for the last 16 h, and the plates were harvested and counted using a β-counter Methods (1450 Microbeta Trilux; Wallac, Gaithersburg, MD).
Mice and synthetic peptides
Colorimetric granzyme B assay Female BALB/c mice, 6-8 weeks of age, were purchased Granzyme B activity was measured using the granzyme from Charles River Japan (Tokyo, Japan PharMingen, San Diego, CA), anti-murine TNF-α mAb (clone MP6-XT22; PharMingen) and anti-murine IL-2 mAb (clone Total RNA was prepared from the CTL using Isogen (Nippon Gene, Toyama, Japan). Then 1 µg of RNA was incubated for S4B6; PharMingen), and anti-murine MIP-1β polyclonal antibody (R & D Systems). 1 h at 42°C after adding 20 U of RNase inhibitors (TaKaRa Biomedicals, Otsu, Japan), 0.2 mM deoxynucleoside triphosphates, 2.5 nM random primers, 11 U of Rous associated virusResults 2 reverse transcriptase (TaKaRa) and reverse transcriptase buffer to a final volume of 20 µl. Quantification of cDNA was
Time course analysis of the cytolytic activity after peptide performed by amplifying the β-actin housekeeping gene.
I-10 treatment Quantified cDNA was then amplified in the presence of 0.2 mM
The CD8 ϩ CTL (LINE-IIIB cells, 1ϫ10 6 cells/ml) specific for deoxynucleoside triphosphates, 2.5 U of Taq polymerase HIV-1 gp160 envelope protein were incubated with 1 µM of (TaKaRa) and 0.5 mM of each primer. The thermal cycle peptide I-10 for 1 h and then washed to remove free peptide. consisted of 30 s at 94°C, 45 s at 55°C for β-actin or 60°C
The treated cells were further incubated for an additional 1, for IL-2, IFN-γ, TNF-α, MIP-1β, granzyme B and perforin, and 2 or 3 days in the absence of antigenic peptide and the 45 s at 72°C. The numbers of PCR cycles (β-actin, 23 cycles; cytolytic activity was assessed at the indicated time points. IL-2, 35 cycles; IFN-γ, 32 cycles; TNF-α, 26 cycles; MIP-1β, 28 As previously reported (11), treatment of the CTL with peptide cycles; perforin, 31 cycles; granzyme B, 31 cycles) were I-10 resulted in marked inhibition of target cell lysis. Time chosen to generate PCR product during the exponential course studies demonstrated that maximum inhibition of the phase of amplification. PCR products were resolved on 2% cytolytic activity occurred on day 1 and the cytolytic activity agarose gels containing ethidium bromide and visualized was restored to a level almost equal to that in untreated under UV light illumination. Primers used in the present study controls over time (Fig. 1A) . The inhibition of cytolytic activity are listed as follows: β-actin sense: 5Ј-ATGGATGACGATwas dependent on the peptide I-10 concentration, and half-ATCGCT-3Ј, β-actin antisense: 5Ј-ATGAGGTAGTCTGTCAmaximum inhibition was achieved between 0.01 and 0.1 µM GGT-3Ј; IL-2 sense: 5Ј-AACAGCGCACCCACTTCAA-3Ј, IL-2 (Fig. 1B) . antisense: 5Ј-TTGAGATGATGCTTTGACA-3Ј; IFN-γ sense: 5Ј-AACGCTACACACTGCATCT-3Ј, IFN-γ antisense: 5Ј-TGCTEffects of peptide I-10 treatment on IL-2-dependent growth CATTGTAATGCTTGG-3Ј; TNF-α sense: 5Ј-GAAAGCATGATCof the CTL CGCGACGTGG-3Ј, TNF-α antisense: 5Ј-GTAGACCTGCCAlthough the CTL used in this study were unable to secrete CGGACTCCGCAA-3Ј; MIP-1β sense: 5Ј-CCACAATAGCAGAdetectable levels of IL-2, they required IL-2 for their prolifera-GAAAVAGCAAT-3Ј, MIP-1β antisense: 5Ј-AACCCCGAGCAAtion. When the CTL were treated with epitopic peptide I-10, CACCATGAAG-3Ј; perforin sense: 5Ј-AGCCAGCGTCTCCA-IL-2-dependent growth was strongly inhibited ( Fig. 2A) . Since GTGAAT-3Ј, perforin antisense: 5Ј-CGCTTCGGGTTCTGTTCthe cell viability determined by the MTT method was not TTC-3Ј; granzyme B sense: 5Ј-GAAGATGCCACCAGTCCTGaffected by treatment with the peptide (data not shown), 3Ј, granzyme B antisense: 5Ј-GAAGATGCCACCAGTCCTGthe unresponsiveness was not ascribed to cell death. The 3Ј.
inhibition of IL-2-dependent CTL growth was corresponding Northern blotting analysis to the peptide concentration. The minimum effective concentration of the peptide was 0.01 µM (Fig. 2B ). Aliquots of 10 µg of total RNA prepared from peptide I-10-treated or untreated CTL were fractionated by electrophoresis Effects of peptide I-10 treatment on the expression of IL-2R in 1.2% agarose gels containing 6% glyoxal and transferred on the CTL on to nylon membranes in 20ϫSSC (175.3 g of NaCl and 88.2 g of sodium citrate in a total volume of 1000 ml, pH 7.0).
Because treatment of the CTL with peptide I-10 induced IL-2 unresponsiveness, we examined the levels of IL-2Rα and The blots were then hybridized with 32 P-labeled probe in Rapid-hybrid buffer (Amersham, Little Chalfont, UK) at 55°C β chain expression on the CTL. The CTL treated with peptide I-10 showed marked down-modulation of IL-2Rβ but not for 2 h. Radioactivity levels were measured using a Fujix BAS 2000 bio-imaging analyzer (Fuji Photo Film, Tokyo, Japan).
IL-2Rα expression. The level of IL-2Rβ down-modulation was highest 1 day after treatment and was gradually restored to Measurement of cytokine activity and contents in culture the control level (Fig. 3A) . IL-2Rβ down-modulation was supernatants dependent on peptide concentration, which was effective at ജ0.01 µM (Fig. 3B) . Although both peptide I-10 and peptide CTLL-2 cells (1ϫ10 4 cells/well), an IL-2-dependent T cell line, were cultured with the samples for 24 h at 37°C. Proliferation MNT10 should bind the H-2D d molecules expressed on the LINE-IIIB cells, only peptide I-10 could be recognized by the of CTLL-2 cells was assessed by the MTT method (19). Concentration of IFN-γ and TNF-α protein contents were TCR of the CTL. Treatment of the CTL with peptide MNT10 induced no effect on either IL-2Rα or β chain expression measured by mouse IFN-γ and TNF-α ELISA kits (BioSource International, Camarillo, CA) respectively. For quantitation of (data not shown). Therefore, the IL-2Rβ down-modulation could not be explained by simple binding of free epitopic MIP-1β, a combination of goat anti-mouse MIP-1β antibody (R & D Systems, Minneapolis, MN) for capturing and biotinylpeptide onto MHC class I molecules of the CTL. expression. In contrast, the levels of FasL mRNA was not Effects of peptide I-10 treatment on granzyme B activity of changed (Fig. 5) .
the CTL Effect of rapamycin (RAP) on the cytolytic activity and the To better understand the mechanism by which peptide I-10
expression of cytolytic molecules inhibits CTL activity, we examined the effects of peptide I-10 on granzyme B activity. We used a colorimetric assay to RAP has potent immunosuppressive properties reflecting the inhibition of T cell activation subsequent to the binding of detect granzyme B enzymatic activity in the CTL lysates. Cell lysates were obtained at various time points after treatment IL-2 to its high-affinity receptor IL-2Rβ (20). To confirm the relationship between signaling through IL-2Rβ and expression of CTL with 1 µM peptide I-10 for 1 h. Significant reduction of granzyme B activity was observed on day 1 and the activity of cytolytic molecules, we examined the effect of RAP on the cytolytic activity and the gene expression of cytolytic was gradually restored thereafter (Fig. 4) . molecules in LINE-IIIB cells. Treatment of the CTL with Effects of peptide I-10 treatment on granzyme B, perforin and 10 ng/ml RAP (Research Biochemicals International, Natick, Fas ligand (FasL) mRNA expression by the CTL MA) for 3 days led to a marked reduction of the cytolytic activity and the gene expression of granzyme B and perforin We next examined the effects of I-10 treatment on the expression of genes associated with T cell-mediated cytotoxicity.
( Fig. 6 ) Total RNA was isolated from the CTL treated with peptide ICytokine activity and contents in the culture supernatants 10 for 1 h and cultured for 24 h. Granzyme B, perforin and FasL gene transcription were assessed by Northern blotting
The culture supernatants of the CTL (I-10 sup) were harvested 1, 2 or 3 days after peptide treatment. I-10 sup harvested on analysis. Treatment of the CTL with peptide I-10 resulted in marked reduction in both Granzyme B and perforin mRNA day 1 contained large amounts of IFN-γ, TNF-α, MIP-1β and IL-2, and the levels of these cytokines were reduced over time (Table 1) . RT-PCR analyses of cDNA from the CTL transcripts reached a maximum at 5 h (Fig. 7) . Treatment of free peptide. After incubation for an additional 1 day, total RNA was the CTL with D d -binding control peptide MNT10 had no effect isolated and mRNA levels were determined by Northern blotting analysis.
on the production of these cytokines (data not shown). Detection sensitivity: IL-2, Ͼ0.1 U/ml; IFN-γ, Ͼ1.0 pg/ml; TNF-α, Ͼ3.0 pg/ml; MP-1β, Ͼ20 pg/ml. a Not detected (below detection sensitivity) Fig. 8 . Enhancement of cytolytic activity by culture supernatants from b Mean Ϯ SD peptide I-10-treated CTL. The CTL were incubated with 1 µM peptide I-10 for 1 h and washed to remove free peptide. After 24 h incubation, the culture supernatants (I-10 sup) were harvested and used for the following experiments. (A) Untreated CTL were incubated with (u) or without (s) I-10 sup for 24 h, and the CTL activity were assessed by 51 Cr-release assay. Next, untreated CTL was incubated with (j) or without (d) I-10 sup for 24 h, then the CTL were washed and incubated with 1 µM peptide I-10 for 1 h. After washing to remove free peptide, the CTL activity was assessed by 51 Cr-release assay.
(B) I-10 sup was treated with 10 µg/ml (final concentration) of anti-IFN-γ, TNF-α, MIP-1β or IL-2 antibody at 37°C for 1 h, then the CTL were added to each treated I-10 sup and cultured for 24 h. After washing with PBS, the CTL activity was assessed by 51 Cr-release assay. Data represent the results at an E:T ratio of 2.5:1 and similar results were obtained in three independent experiments. A, no treatment of the CTL (NTC); B, addition I-10 sup to NTC; C, addition anti-IFN-γ antibody-treated I-10 sup to NTC; D, addition anti-MIP-1β antibody-treated I-10 sup to NTC; E, addition anti-TNF-α antibodytreated I-10 sup to NTC; F, addition anti-IL-2 antibody-treated I-10 sup to NTC; G, addition human rIL-2 (1000 U/ml) to NTC by I-10 sup. However, the enhancement was significantly but days, total RNA was isolated and mRNA levels were determined by partially inhibited by the addition of anti-IL-2 antibody. As semiquantitative RT-PCR.
has shown in Table 1 , I-10 sup contained~100 U/ml of IL-2. Nevertheless, the enhancement of the cytolytic activity mediated by a high concentration of recombinant IL-2 was not comparable to that obtained by I-10 sup (Fig. 8B ). This Therefore, the I-10 sup contained various cytokines produced finding strongly indicates the existence of other factors in I-10 and secreted by I-10-treated CD8 ϩ CTL.
sup which cooperate with IL-2 to enhance the cytolytic activity.
Effects of I-10 sup on the CTL
Effect of antigenic peptide on the cytolytic activity and cytokine We asked whether the CTL exposed to free peptide secreted production of ovalbumin (OVA)-specific CTL factors that affected the activity of other CTL. The CTL were treated with 1 µM peptide I-10 for 1 h and washed to remove
To confirm whether the findings in this report, in which treatment of the CTL with their antigenic peptide induce a free peptide. After incubation for 24 h, the culture supernatants (I-10 sup) were harvested and used for the following experimarked inhibition of cytolytic activity but enhancement of cytokine production, are generalizable, we performed similar ments. At first, to examine the effect of the I-10 sup on the cytolytic activity, unstimulated CTL were cultured with I-10 experiments using another set of CTL and their specific peptide: H-2 b -restricted OVA-specific CTL and peptide (amino sup for 24 h and the cytolytic activity was determined. We observed marked enhancement of the cytolytic activity by acids 257-264, SIINFEKL) (21,22) (Y. Nakagawa and H. Takahashi, unpublished observation). As expected, treattreatment of unstimulated CTL with I-10 sup ( Fig. 8A and B) . However, the degree of inhibition of cytolytic activity caused ment of OVA-specific CTL with their antigenic peptide resulted in marked inhibition of cytolytic activity, whereas both IFN-γ by free peptide I-10 remained the same in I-10 sup-treated and untreated CTL (Fig. 8A) . To clarify the actual elements in production and gene expression in peptide-treated CTL were significantly enhanced (Fig. 9 ). These observations indicate I-10 sup responsible for the enhancement of cytolytic activity, we added anti-IFN-γ, TNF-α, MIP-1β or IL-2 neutralizing that counter-regulation between cytolytic activity and cytokine production in the CTL by their free antigenic peptides seems antibody to I-10 sup. Addition of anti-IFN-γ, TNF-α or MIP-1β only marginally affected the enhancement of cytolytic activity to apply to CTL of multiple specificities.
CRE and CRE-like binding motifs, they speculated on a mechanism by which RAP could reduce granzyme B and perforin gene transcription. Their findings suggested that signaling through the IL-2R was involved in the regulation of cytolytic molecule expression. Since the blockage of the IL-2R signaling by RAP also reduced the expression of cytolytic activity, granzyme B and perforin in our CTL, down-modulation of IL-2Rβ by peptide I-10 might be implicated in the inhibition of the cytolytic response by down-regulating the expression of granzyme B and perforin. If signaling through IL-2R is linked to the expression of cytolytic molecules, the IL-2R pathway should regulate not only T cell proliferation but also the cytolytic activity. In this study, we demonstrated that the reduction and restoration of peptide-induced changes in the expression of IL-2Rβ were well correlated with those in both the cytolytic activity and IL-2-dependent cell growth. Although we have not yet determined the pathway responsible for IL-2Rβ down-modulation, our findings suggest that there might be intracellular signal pathways through the TCR that regulate IL-2Rβ expression, followed by induction of both cytolytic activity and IL-2- by the CTL (26) . In this study, we showed that when unstimulated CTL were In contrast, since treatment with peptide I-10 did not decrease FasL mRNA levels in the CTL and cytolytic activity was not cultured with I-10 sup, their cytolytic activity was markedly enhanced. Although this enhancing effect of I-10 sup on the affected by anti-FasL antibody (data not shown), the inhibition of cytolytic activity may not be due to CTL damage or CTL activity was significantly inhibited by anti-IL-2 antibody, such enhancement could not be fully substituted with recomelimination by apoptosis, but may mainly be due to the exhaustion and reduction of granzyme B and perforin content.
binant IL-2. Therefore, other factors in I-10 sup must also up-regulate the cytolytic activity in the presence of IL-2. For IL-2 has been shown to be required for generation and proliferation of the CTL in vitro, and for up-regulation of the example, IL-15, which also uses the IL-2Rβ receptor, may be involved (27, 28) . However, since there is no anti-IL-15 antiexpression of perforin, granzyme B and FasL (20, 22, 23) . However, the relevance of signaling through the IL-2R to the body for the mouse, we cannot block with that as we did with the other cytokines. The epitopic peptide-treated CTL showed expression of the cytolytic molecules remains to be elucidated. Recently, Makrigiannis and Hoskin (20) reported that CTL loss of their cytolytic activity, but at the same time they gained the ability to produce cytokines enhancing unstimulated T cell generated in the presence of RAP exhibited reduced cellular proliferation and cytolytic activity against the target cells. They functions. These findings suggest that treatment with peptide I-10 transiently converted the CD8 ϩ CTL into cells of T h demonstrated that this suppressive effect of RAP on CTL induction was partially due to the inhibition of granzyme B cell function. The highest levels of cytokines were produced in the culture and perforin gene expression. As RAP inhibited the activity of a cAMP-responsive element (CRE) binding protein induced supernatant when the cytolytic activity level was the lowest. Sad et al. showed that CD8 ϩ T cells from perforin-deficient by IL-2, and both granzyme B and perforin genes contain
